Actionable news
All posts from Actionable news
Actionable news in BLUE: bluebird bio, Inc.,

bluebird bio to Present at Four Upcoming Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies for cancer, today announced that members of the management team will present at the following upcoming investor conferences:

  • Citi 11th Annual Biotech Conference on September 7, 2016. Panel discussion at 1:00 p.m. ET at the Mandarin Oriental Hotel in Boston.
  • Wells Fargo Securities Healthcare Conference, on September 8, 2016, 9:20 a.m. ET at the Westin Waterfront in Boston.
  • Morgan Stanley Global Healthcare Conference on September 13, 2016, 4:05 p.m. ET at the Grand Hyatt in New York.
  • LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology on September 29, 2016 at 2:00 p.m. ET at the Lotte New York Palace in New York.

To access the live webcast of bluebird bio’s presentations, please visit the “Events & Presentations” page within the Investors and Media section of the bluebird bio website at Replays of the webcasts will be available on the bluebird bio website for 90 days following the conferences.

About bluebird bio, Inc.

With its lentiviral-based gene therapies, T cell immunotherapy expertise and gene editing capabilities, bluebird bio has built an integrated product platform with broad...